Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796323 · ClinicalTrials.gov registry record
Perceptions and Prevalence of Workplace Violence in Healthcare
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT05796323: Completed study, sponsored by Methodist Health System.
NCT05796323 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05796323 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
Workplace violence includes physical and verbal aggression as well as threatening behavior. All types of workplace violence incidents in health care are often under-reported, especially if there is no lasting physical injury.
Primary Outcome
Research Instruments Survey Questionnaire used to measure physical and psychological characteristics of violence at work
Interventions
- OTHER No intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2025-07-29 |
What the finished NCT05796323 record still lists
NCT05796323 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No intervention. is the first listed.
NCT05796323 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05796323 about?
NCT05796323 is a clinical study titled "Perceptions and Prevalence of Workplace Violence in Healthcare". Workplace violence includes physical and verbal aggression as well as threatening behavior. All types of workplace violence incidents in health care are often under-reported, especially if there is no lasting physical injury.
What is the current status of trial NCT05796323?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2022-03-16. Estimated completion is 2025-07-29.
What interventions are being tested in trial NCT05796323?
The interventions under investigation include: No intervention. (OTHER).
Who is sponsoring clinical trial NCT05796323?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI